Phase 1 Safety, Tolerability and PK Study of Ondansetron and Hylenex Recombinant in Healthy Volunteers

This study has been completed.
Information provided by (Responsible Party):
Halozyme Therapeutics Identifier:
First received: April 3, 2012
Last updated: January 22, 2014
Last verified: January 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2013
  Primary Completion Date: November 2013 (Final data collection date for primary outcome measure)
No publications provided by Halozyme Therapeutics

Publications automatically indexed to this study by Identifier (NCT Number):